HAE — Haemonetics Corporation · P/E 35, rev $1.33B

Haemonetics Corporation (HAE) is a medical devices company listed on US.

Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.

Use this HAE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HAE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HAE SEC filings page. Lician reads the product cache first so this HTML stays unique to Haemonetics Corporation even when a live quote feed is slow.